Pneumologie 2006; 60(11): 672-678
DOI: 10.1055/s-2006-944272
© Georg Thieme Verlag Stuttgart · New York

Klinische Bedeutung des gastroösophagealen Refluxes beim Asthma bronchiale

Clinical Significance of Gastrooesophageal Reflux in AsthmaT.  Rothe1 , R.  Buhl2 , A.  Gillissen3 , P.  Kardos4 , K.  F.  Rabe5 , R.  Sauer6 , C.  Vogelmeier7 , H.  Worth8 , R.  Arnold9 , G.  Menz10
  • 1Luzerner Höhenklinik Montana, CH
  • 2Pneumologie, Johannes Gutenberg-Universität Mainz
  • 3Pneumologie, Robert-Koch-Klinik Leipzig
  • 4Pneumologie/Allergologie-Zentrum Krankenhaus Maingau, Frankfurt/Main
  • 5Dept. Pulmology, University Leiden, NL
  • 6Pneumologie-Praxis Ulm
  • 7Pneumologie, Philipps-Universität Marburg
  • 8Medizinische Klinik Fürth
  • 9Gastroenterologie, Philipps-Universität Marburg
  • 10Hochgebirgsklinik Davos, Schweiz
Further Information

Publication History

eingereicht 29. 5. 2006

akzeptiert 17. 7. 2006

Publication Date:
16 November 2006 (online)


Im klinischen Alltag koinzidieren asthmatische Beschwerden und gastroösophagealer Reflux (GÖR) häufig. Bei der Behandlung einer gastroösophagealen Refluxkrankheit muss ein parallel bestehendes Asthma dann nicht mitberücksichtigt werden, wenn das Asthma gut kontrolliert ist. Im Falle eines symptomatischen Asthmas, das auch auf eine Therapieintensivierung nicht, oder nur unzureichend anspricht, besteht jedoch die Möglichkeit, dass der GÖR und die Therapierefraktärität des Asthmas in einem kausalen Zusammenhang stehen. Ein Algorithmus soll in diesem Fall das klinische Vorgehen leiten.


In clinical practice, gastrooesophageal reflux (GER) and bronchial asthma often coincide. In the case of sufficient asthma control, the asthma does not need to be taken into account when treatment of GER is being evaluated. In patients with symptomatic asthma despite adequate antiasthmatic treatment, a possible causal relationship between GER and the poor responsiveness to asthma therapy has to be considered. An algorithm to guide the diagnostic and therapeutic steps in such cases is presented.


  • 1 Kiljander T O, Laitinen J O. The prevalence of gastroesophageal reflux disease in adult asthmatics.  Chest. 2004;  126 1490-1494
  • 2 Harding S M, Guzzo M R, Richter J E. 24 hour esophageal pH testing in asthmatics. Respiratory symptom correlation with esophageal acid events.  Chest. 1999;  115 654
  • 3 Irwin R S, Curley F J, French C L. Difficult to control asthma: Contributing factors and outcome of a systematic management protocol.  Chest. 1993;  103 1662
  • 4 Dent J, El-Serag H B, Wallander M A. et al . Epidemiology of gastrooesophageal reflux disease: a systematic review.  Gut. 2005;  3 543
  • 5 Fass R, Quan S F, O'Connor G T. et al . Predictors of heartburn during sleep in a large prospective cohort study.  Chest. 2005;  127 1658-1666
  • 6 Koop H, Schepp W, Müller-Lissner S. et al . Gastroösophageale Refluxkrankheit - Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterol. 2005;  43 163-194 (
  • 7 Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität .24-Stunden-Ösophagus-pH-Metrie. 
  • 8 Schindlbeck N E, Ippisch H, Klauser A G. et al . Which pH threshold is best in esophageal pH monitoring.  Am J Gastroenterol. 1991;  86 1138-1141
  • 9 Jamieson J R, Stein H J, DeMeester T R. et al . Ambulatory 24-h esophageal pH monitoring: normal values, optimal threshold, specificity, sensitivity, and reproducibility.  Am J Gastroenterol. 1992;  87 1102-1111
  • 10 Kahrilas P J, Quigley E M. Clinical esophageal pH recording: a technical review for practice guideline development.  Gatroenterology. 1996;  110 1982-1996
  • 11 Irwin R S, French C L, Curley F J. Chronic cough due to gastroesophageal reflux: clinical, diagnostic, and pathogenetic aspects.  Chest. 1993;  104 1511
  • 12 Hunt J, Yu Y, Burns J. et al . Identification of acid reflux cough using serial assays of exhaled breath condensate pH.  Cough. 2006;  2 3
  • 13 Kardos P, Cegla U, Gillissen A. et al . Leitlinie der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit akutem und chronischem Husten.  Pneumologie. 2004;  58 570-602
  • 14 Chang A B, Lasserson T J, Kiljander T O. et al . Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux.  BMJ. 2006;  332 11-14
  • 15 Irwin R S, Curley F J, French C L. Chronic cough: The sprectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy.  Am Rev Respir Dis. 1990;  141 640-647
  • 16 Ing A J, Ngu M C, Breslin A B. et al . Pathogenesis of chronic cough associated with gastroesophageal reflux.  Am J Respir Crit Care Med. 1994;  149 160-167
  • 17 Wong R K, Hanson D G, Waring P J. et al . ENT manifestations of gastroesophageal reflux.  Am J Gastroenterology. 2000;  95 (Suppl. 8) S15-S22
  • 18 Poelmans J, Tack J. Extraesophageal complications of gastroesophageal reflux.  Gut. 2005;  54 1492-1499
  • 19 Powell D M, Karanfilov B I, Beechler K B. et al . Paradoxical vocal cord dysfunction in juveniles.  Arch Otolaryngol Head Neck Surg. 2000;  126 29-34
  • 20 Kerr P, Shoenut J P, Millar T. et al . Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome.  Chest. 1992;  101 1539-1544
  • 21 Harding S M, Guzzo M R, Richter J E. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms.  Am Rev Respir Crit Care Med. 2000;  162 34-39
  • 22 Ruth M, Carlsson S M, Haile J M. et al . Scintigraphic detection of gastroesophageal aspiration in patients with respiratory disorders.  Clin Physiol. 1993;  13 19-33
  • 23 Mohklesi B, Morris A L, Huang C F. et al . Increased prevalence of gastroesophageal reflux in patients with COPD.  Chest. 2001;  119 1043-1048
  • 24 Tobin R W, Pope C E, Pellegrini C A. et al . Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.  Am Rev Respir Crit Care Med. 1998;  158 1804-1808
  • 25 Nordenstedt H, Nilson M, Johansson S. et al . The relation between gastroesophageal reflux and respiratory symptoms in a population-based study.  Chest. 2006;  129 1051-1056
  • 26 Osler W B. Bronchial asthma. In: The principles and practice of medicine. New York: NY. Appleton 1892: 497-501
  • 27 Peterson W L. American gastroenterological association consensus development panel: improving the management of GERD ( 
  • 28 Sontag S J, O'Connell S, Khandelwal T. et al . Most asthmatic patients have gastroesophageal with or without bronchodilator therapy.  Gastroenterology. 1990;  99 613-620
  • 29 Stein M R, Towner T G, Weber R W. et al . The effect of theophylline on the lower esophageal sphincter pressure.  Ann Allergy. 1980;  45 238-241
  • 30 DiMarino A J, Cohen S. Effect of an oral beta-2 adrenergic agonist on lower esophageal sphincter pressure in normal and in patients with achalasia.  Dig Dis Sci. 1982;  27 1063-1066
  • 31 Crowell M D, Zayat E N, Lacy B E. et al . The effects of an inhaled beta-2-adrenergic agonist on lower esophageal function.  Chest. 2001;  120 1184-1189
  • 32 Michoud M C, Leduc T, Proulx F. et al . Effect of salbutamol on gastroesophageal reflux in healthy volunteers and patients with asthma.  J Allergy Clin Immunol. 1991;  87 762-767
  • 33 Huber D, Gaudric M, Guerre J. et al . Effect of theophylline on gastroesophageal reflux in patients with asthma.  J Allergy Clin Immunol. 1988;  81 1168-1174
  • 34 Lazenby J P, Guzzo M R, Harding S M. et al . Oral corticosteroids increase esopagheal contact times in patients with asthma.  Chest. 2002;  121 625-634
  • 35 Zerbib F, Guisset O, Lamouliatte H. et al . Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma.  Am J Respir Crit Care Med. 2002;  166 1206-1211
  • 36 Avidan B, Sonnenburg A, Schnell T G. et al . Temporal associations between coughing or wheezing and cid reflux in asthmatics.  Gut. 2001;  49 767-772
  • 37 Mello C J, Irwin R S, Curley F J. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause.  Arch Intern Med. 1996;  156 997-1003
  • 38 Irwin R S, Zawacki J K, Curlwy F J. et al . Chronic cough as the sole presenting manifestation of gastroesophageal reflux.  Am Rev Respir Dis. 1989;  140 1294-1300
  • 39 Spaulding Jr  H S, Mansfield L E, Stein M R. et al . Further investigation of the association between gastroesophageal reflux and bronchoconstriction.  J Allergy Clin Immunol. 1982;  69 516-521
  • 40 Larrain A, Carrasco E, Galleguillos F. et al . Medical and surgical treatment of nonallergic asthma associated with gastroesophageal relux.  Chest. 1991;  99 1330-1335
  • 41 Ruigomez A, Rodriguez L A, Wallander M-A. et al . Gastroesophageal reflux disease and asthma: A longitudinal study in UK general practice.  Chest. 2005;  128 85-93
  • 42 Herve P, Denjeen A, Jian R. et al . Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects.  Am Rev Respir Dis. 1986;  134 986-989
  • 43 Jack C I, Calverley P M, Donelly R J. et al . Simultaneous tracheal and esophageal pH measurements in asthmatic patients with gastroesophageal reflux.  Thorax. 1995;  50 201-204
  • 44 ten Brinke A, Sterk P J, Masclee A A. et al . Risk factors of frequent exacerbations in difficult-to-treat-asthma.  Eur Respir J. 2005;  26 812-818
  • 45 Field S K, Sutherland L R. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature.  Chest. 1998;  114 274-283
  • 46 Heaney L G, Conway E, Kelly C. et al . Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol.  Thorax. 2003;  58 561-566
  • 47 Leggett J J, Johnston B T, Mills M. et al . Prevalence of gastroesophageal reflux in difficult asthma. Relationship to asthma outcome.  Chest. 2005;  127 1227-1231
  • 48 Littner M R, Leung F W, Ballard E D. et al . Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exazerbations, quality of lief, and pulmonary function in adult asthmatic patients with acid reflux symptoms.  Chest. 2005;  128 1128-1135
  • 49 Størdal K, Johannesdottir G B, Bentsen B S. et al . Acid suppression does not change respiratory symptoms in children with asthma and gastro-esophageal reflux disease.  Arch Dis Child. 2005;  90 956-960
  • 50 Gibson P G, Henry H L, Coughlan J L. Gastro-oesophageal reflux treatment for asthma in adults and children.  Syst Rev. 2003;  (2) CDOOI1496
  • 51 Milkes D, Gerson L B, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease.  Am J Gastroenterology. 2004;  99 991-996
  • 52 Vela M F, Camacho-Lobato L, Srinivasan R. et al . Simultaneous intraesophageal impedance and pH measurement ofacid and nonacid gastroesophageal reflux: effect of omeprazole.  Gastroenterology. 2001;  120 1599-1606
  • 53 Sontag S J, O'Connell S, Khandelwal S. et al . Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.  Am J Gastrenterology. 2003;  98 987-999
  • 54 Khoshoo V, Le T, Haydel M. Role of gastroesophageal reflux in older children with persistent asthma.  Chest. 2003;  123 1008-1013
  • 55 Rensburg C J van, Bardhan K D. No clinical benefit of adding cisapride to pantoprapzole for treatment of gastro-oesophageal reflux disease.  Eur J Gastroenterol Hepatol. 2001;  13 909-914
  • 56 Smythe A, Bird N C, Troy G P. et al . Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?.  Eur J Gastroenterol Hepatol. 2003;  15 305-312
  • 57 Harding S M, Richter J E, Guzzo M R. Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome.  Am J Med. 1996;  100 395-405
  • 58 Kiljander T O, Harding S M, Field S K. et al . Effects of Esomeprazole 40 mg twice daily on asthma. A randomized Plazebo-controlled trial.  Am J Respir Crit Care Med. 2006;  173 1091-1097
  • 59 Dennis S M, Altmann D R, Lee T H. et al . Increase in daytime symptoms is a sensitive and specific criterion for predicting corticosteroid-treated exacerbations in a clinical asthma trial.  Clin Exp Allergy. 2005;  35 308-312
  • 60 McIvor R A, Pizzichini E, Turner M O. et al . Potential masking effect of salmeterol on airway inflammation in asthma.  Am J Respir Crit Care Med. 1998;  158 924-930
  • 61 Poe R H, Kallay M C. Chronic cough and gastroesophageal reflux disease. Experience with specific therapy for diagnosis and treatment.  Chest. 2003;  123 679-684
  • 62 Fox M, Forgacs I. Gastro-oesophageal reflux disease.  BMJ. 2006;  332 88-93
  • 63 Menz G, Buhl R, Gillissen A. et al . Schwieriges Asthma: Klinische Phänotypen und Prinzipien der Therapie.  Pneumologie. 2002;  56 132-137
  • 64 Tobin J M, McCloud P, Cameron D J. Posture and gastro-oesophageal reflux: a case for left lateral positioning.  Arch Dis Child. 1997;  76 254-258
  • 65 Johnson L F, DeMeesters T R. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux.  Dig Dis Sci. 1981;  26 673-680

PD Dr. Günter Menz

Hochgebirgsklinik Davos

7265 Davos-Wolfgang